(Q34089060)

30 July 2017

1 reference

title

Trends over time in the incidence of cervical neoplasia in comparison to trends over time in human papillomavirus infection (English)

1 reference

Papillomavirus infections

30 July 2017

1 reference

Dillner J

1

1 reference

30 July 2017

1 October 2000

1 reference

Journal of Clinical Virology

30 July 2017

1 reference

30 July 2017

19

1 reference

30 July 2017

7-23

1 reference

30 July 2017

1-2

1 reference

Stability over time of serum antibody levels to human papillomavirus type 16.

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969-1989.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among children

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

No serological evidence for non-sexual spread of HPV16

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

A prospective study on the risk of cervical intra-epithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

The serological response to papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

High risk genital papillomavirus infections are not spread vertically

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Human papillomavirus infection is transient in young women: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

The Sexually Transmitted Disease Model for Cervical Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Transmission of Cervical Human Papillomavirus Infection by Sexual Activity: Differences between Low and High Oncogenic Risk Types

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Determinants of genital human papillomavirus infection in low-income women in Washington, D.C.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Persistence of type-specific human papillomavirus infection among cytologically normal women

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Natural history of cervicovaginal papillomavirus infection in young women.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Human papillomavirus, herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark)--a second look.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Identification of a cytotoxic T-lymphocyte epitope in the human papillomavirus type 16 E2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Chlamydia trachomatis infection as a risk factor for invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Human T helper cell epitopes overlap B cell and putative cytotoxic T cell epitopes in the E2 protein of human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Vaccination against colonizing bacteria with multiple serotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Detection of human papillomavirus type 16 DNA and of antibodies to human papillomavirus type 16 proteins in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populations

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

A population-based case-control study of human papillomavirus-type-16 seropositivity and incident high-grade dysplasia of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

The impact of screening on the incidence of cervical cancer in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Has screening for cervical cancer been successful?

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Risk factors for genital papillomavirus infection in populations at high and low risk for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Papillomavirus is resistant to desiccation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Effect of smoking cessation on cervical lesion size.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Type specificity and significance of different isotypes of serum antibodies to human papillomavirus capsids

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and-negative women

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

International trends in incidence of cervical cancer: II. Squamous-cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Identification of human papillomavirus seroconversions

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Prospective study on the development of antibodies against human papillomavirus type 6 among patients with condyloma acuminata or new asymptomatic infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

Smoking and oral contraceptives as risk factors for cervical carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900126-8

7 January 2021

10.1016/S1386-6532(00)00126-8

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11091144